Response to Parenteral Triamcinolone in Severe Asthma: A Useful Induced Phenotype for Clinicians?
- PMID: 33449842
- PMCID: PMC8017573
- DOI: 10.1164/rccm.202012-4485ED
Response to Parenteral Triamcinolone in Severe Asthma: A Useful Induced Phenotype for Clinicians?
Comment on
-
Responsiveness to Parenteral Corticosteroids and Lung Function Trajectory in Adults with Moderate-to-Severe Asthma.Am J Respir Crit Care Med. 2021 Apr 1;203(7):841-852. doi: 10.1164/rccm.202002-0454OC. Am J Respir Crit Care Med. 2021. PMID: 33290668 Free PMC article.
References
-
- Loza MJ, Djukanovic R, Chung K-F, Horowitz D, Ma K, Branigan P, et al. ADEPT (Airways Disease Endotyping for Personalized Therapeutics) and U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome Consortium) investigators. Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study. Respir Res. 2016;17:165. - PMC - PubMed
-
- Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, et al. National Heart, Lung, Blood Institute’s Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program. J Allergy Clin Immunol. 2007;119:405–413. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
